Signaling molecules derived from the cholesterol biosynthetic pathway: mechanisms of action and possible roles in human disease

被引:38
作者
Edwards, PA
Ericsson, J
机构
[1] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA
关键词
D O I
10.1097/00041433-199810000-00007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The association of high plasma cholesterol levels with the development of atherosclerosis is well known. The metabolic pathways that are regulated by cholesterol and the mechanisms involved are less well understood. Recent studies have identified not only cholesterol, but also oxysterols and isoprenoids, derived from the cholesterol biosynthetic pathway, as new signaling molecules. The transcriptional and post-transcriptional regulation of specific genes and metabolic pathways by these newly discovered signaling molecules may be important in the development of human disease and forms the topic of this review. Curr Opin Lipidol 9:433-440. (C) 1998 Lippincott Williams & Wilkins
引用
收藏
页码:433 / 440
页数:8
相关论文
共 85 条
  • [1] Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity
    Aslanidis, C
    Ries, S
    Fehringer, P
    Buchler, C
    Klima, H
    Schmitz, G
    [J]. GENOMICS, 1996, 33 (01) : 85 - 93
  • [2] Specificity in cholesterol regulation of gene expression by coevolution of sterol regulatory DNA element and its binding protein
    Athanikar, JN
    Osborne, TF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) : 4935 - 4940
  • [3] BABIKER A, 1997, J BIOL CHEM, V272, P62653
  • [4] The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    Berkhout, TA
    Simon, HM
    Patel, DD
    Bentzen, C
    Niesor, E
    Jackson, B
    Suckling, KE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) : 14376 - 14382
  • [5] Importance of a novel oxidative mechanism for elimination of brain cholesterol - Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with O-18(2) techniques in vivo and in vitro
    Bjorkhem, I
    Lutjohann, D
    Breuer, O
    Sakinis, A
    Wennmalm, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) : 30178 - 30184
  • [6] The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
    Brown, MS
    Goldstein, JL
    [J]. CELL, 1997, 89 (03) : 331 - 340
  • [7] Niemann-Pick C1 disease gene: Homology to mediators of cholesterol homeostasis
    Carstea, ED
    Morris, JA
    Coleman, KG
    Loftus, SK
    Zhang, D
    Cummings, C
    Gu, J
    Rosenfeld, MA
    Pavan, WJ
    Krizman, DB
    Nagle, J
    Polymeropoulos, MH
    Sturley, SL
    Ioannou, YA
    Higgins, ME
    Comly, M
    Cooney, A
    Brown, A
    Kaneski, CR
    BlanchetteMackie, EJ
    Dwyer, NK
    Neufeld, EB
    Chang, TY
    Liscum, L
    Strauss, JF
    Ohno, K
    Zeigler, M
    Carmi, R
    Sokol, J
    Markie, D
    ONeill, RR
    vanDiggelen, OP
    Elleder, M
    Patterson, MC
    Brady, RO
    Vanier, MT
    Pentchev, PG
    Tagle, DA
    [J]. SCIENCE, 1997, 277 (5323) : 228 - 231
  • [8] Protein prenyltransferases
    Casey, PJ
    Seabra, MC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (10) : 5289 - 5292
  • [9] CHISOLM GM, 1991, CURR OPIN LIPIDOL, V2, P311
  • [10] Disorders of cholesterol biosynthesis
    Clayton, PT
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1998, 78 (02) : 185 - 189